Corporate Governance | Regeneron Pharmaceuticals Inc.

Date	Name	Title	Filing	Type	Shares Traded	Price	Total Held
Jan 09, 2004	YANCOPOULOS GEORGE Director, EVP, CSO, & Pres Regn Res Labs	Director, EVP, CSO, & Pres Regn Res Labs	Form 4	Open market or private sale of non-derivative or derivative security	17	$15.53	64,681
Jan 09, 2004	YANCOPOULOS GEORGE Director, EVP, CSO, & Pres Regn Res Labs	Director, EVP, CSO, & Pres Regn Res Labs	Form 4	Open market or private sale of non-derivative or derivative security	17	$15.48	64,664
Jan 09, 2004	YANCOPOULOS GEORGE Director, EVP, CSO, & Pres Regn Res Labs	Director, EVP, CSO, & Pres Regn Res Labs	Form 4	Open market or private sale of non-derivative or derivative security	17	$15.47	64,647
Jan 09, 2004	YANCOPOULOS GEORGE Director, EVP, CSO, & Pres Regn Res Labs	Director, EVP, CSO, & Pres Regn Res Labs	Form 4	Open market or private sale of non-derivative or derivative security	51	$15.35	64,596
Jan 09, 2004	YANCOPOULOS GEORGE Director, EVP, CSO, & Pres Regn Res Labs	Director, EVP, CSO, & Pres Regn Res Labs	Form 4	Open market or private sale of non-derivative or derivative security	17	$15.34	64,579
Jan 09, 2004	YANCOPOULOS GEORGE Director, EVP, CSO, & Pres Regn Res Labs	Director, EVP, CSO, & Pres Regn Res Labs	Form 4	Open market or private sale of non-derivative or derivative security	490	$15.32	64,089
Jan 09, 2004	YANCOPOULOS GEORGE Director, EVP, CSO, & Pres Regn Res Labs	Director, EVP, CSO, & Pres Regn Res Labs	Form 4	Open market or private sale of non-derivative or derivative security	307	$15.30	63,782
Jan 09, 2004	YANCOPOULOS GEORGE Director, EVP, CSO, & Pres Regn Res Labs	Director, EVP, CSO, & Pres Regn Res Labs	Form 4	Open market or private sale of non-derivative or derivative security	34	$15.26	63,748
Jan 09, 2004	YANCOPOULOS GEORGE Director, EVP, CSO, & Pres Regn Res Labs	Director, EVP, CSO, & Pres Regn Res Labs	Form 4	Open market or private sale of non-derivative or derivative security	135	$15.25	63,613
Jan 09, 2004	YANCOPOULOS GEORGE Director, EVP, CSO, & Pres Regn Res Labs	Director, EVP, CSO, & Pres Regn Res Labs	Form 4	Open market or private sale of non-derivative or derivative security	17	$15.24	63,596

* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.

Investors & Media